🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial is studying how well romidepsin works in treating patie...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center at Suffolk
Start Date
2004-10
Trial ID
NCT00098813
Treatments Being Tested
This study evaluates the safety and tolerability of the addition of immunos...
Status
Terminated
Location
NYU Cancer Institute
Start Date
2014-03
Trial ID
NCT02061449
Treatments Being Tested
This phase I trial studies the side effects and best dose of romidepsin in ...
Status
Completed
Location
City of Hope Comprehensive Cancer Center
Start Date
2012-08-03
Trial ID
NCT01638533
Treatments Being Tested
Primary objective of the study is to compare the efficacy of romidepsin whe...
Status
Completed
Location
ZNA Stuivenberg
Start Date
2013-01
Trial ID
NCT01796002
Treatments Being Tested
The goal of this clinical research study is to learn if giving romidepsin b...
Status
Completed
Location
The Ohio State University Cancer Center
Start Date
2017-12-08
Trial ID
NCT02512497
Treatments Being Tested
This pilot clinical trial studies the feasibility of choosing treatment bas...
Status
Completed
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2015-09-11
Trial ID
NCT02551718
Background: Advanced urothelial cancer has no cure. But only a few chemoth...
Status
Completed
Location
National Institutes of Health Clinical Center
Start Date
2017-03-27
Trial ID
NCT02788201
Treatments Being Tested
The purpose of this study is to evaluate the activity of FK228 in metastati...
Status
Completed
Location
City of Hope National Medical Center
Start Date
2003-05-01
Trial ID
NCT00106613
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cel...
Status
Completed
Location
Arthur G. James Cancer Hospital - Ohio State University
Start Date
2002-01
Trial ID
NCT00024180
Treatments Being Tested